Cited 76 times in
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.